Back to insights
In the News

"New Hope for IPOs": EquityZen's Brianne Lynch on Bloomberg Technology

EquityZen
Written by EquityZen
•
June 3, 2025
•
0 min read

In this article

    EquityZen's Head of Market Insight, Brianne Lynch joined “Bloomberg Technology” with Caroline Hyde to discuss how the successful market debuts for eToro, MNTN, and Hinge Health are boosting confidence for tech investors and startups eyeing future IPOs.

    Check out the full interview on Bloomberg: New Hope for IPOs 

    There are inherent risks in pre-IPO investments, including the risk of loss of the entire investment, illiquidity, and fluctuations in value and returns.

     

    Join Investors and Shareholders Exploring the Private Markets Today

    Get Started

    Related Articles

    Fox Business: 'Zombie stocks' exacerbating the IPO drought
    Fox Business: 'Zombie stocks' exacerbating the IPO drought

    What's cooling the IPO market? Hear thoughts from EquityZen's Phil Haslett on 'The Claman Countdown'...

    In the News
    <1 min read
    Bloomberg: Venture Capitalists Stare Into the Post-SVB Abyss
    Bloomberg: Venture Capitalists Stare Into the Post-SVB Abyss

    Though we’re past the initial shock, SVB’s collapse is having longer-term consequences for the broad...

    IPO News
    <1 min read
    Circle IPO: Unveiling the Largest Shareholders
    Circle IPO: Unveiling the Largest Shareholders

    Discover Circle's largest shareholders! See who owns big stakes in the USDC issuer's IPO, including ...

    Market Views
    2 min read

    The Potential to Shape the Future

    Join over 700,000 investors and shareholders accessing the private markets with EquityZen

    Get Started

    Company

    Policies & Disclosures

    Help

    Connect

    Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

     

    EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the U.S. Securities and Exchange Commission and is a FINRA/SIPC member firm.

     

    Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

     

    EquityZen Inc. was awarded a 2024 Fintech Breakthrough Award by Tech Breakthrough LLC on March 19, 2025, based on the prior year and covering calendar year 2024, and has compensated FinTech Breakthrough LLC for use of its name and logo in connection with the award. FinTech Breakthrough LLC is a third party and has no affiliation with EquityZen.

     

    EquityZen created the ticker symbols referenced on this page for use solely on the EquityZen platform. They do not refer to any publicly traded stock. EquityZen does not have an affiliation with, formal relationship with, or endorsement from any of the companies featured and none of the statements on the site should be attributed to those companies.

     

    “Market Activity” and other transactional data displayed on this website is compiled by EquityZen and is confidential and historical in nature. Unauthorized use, distribution or reproduction is prohibited. Transactional information does not guarantee future investment results. EquityZen cannot guarantee finding or approving a transaction at any displayed price.

     

    EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.

    EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
    © 2025 EquityZen. All rights reserved.

    EquityZen Inc.
    30 Broad Street,
    Suite 1200
    New York, NY 10004

    Trustpilot

    Secured via DigiCert Extended Validation certificate

    FINRA's BrokerCheck

    SIPCFinTech Breakthrough Award